With a 2024 market valuation of USD 5.62 billion and a projected CAGR of 9.5% through 2034, the global pediatric diabetes management market is being shaped by concentrated national healthcare investments, evolving regulatory frameworks, and strategic positioning among leading medical device manufacturers. Leading countries such as the United States, Germany, Japan, and Canada are at the...